Inagi, Japan

Kenyu Shibata


Average Co-Inventor Count = 8.6

ph-index = 3

Forward Citations = 115(Granted Patents)


Location History:

  • Inagi, JP (1981 - 1996)
  • Tokyo, JP (1996)

Company Filing History:


Years Active: 1981-1996

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Kenyu Shibata: A Patent Profile

Introduction: Kenyu Shibata, an accomplished inventor based in Inagi, Japan, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 10 patents, his work primarily focuses on steroid compounds with potential applications in various therapeutic areas.

Latest Patents: Among his latest innovations, Shibata has developed several compounds, including the 7-substituted oxa- or azasteroid compound and various oxa- or azasteroid derivatives. These patented advancements highlight his expertise in creating novel compounds that are essential for medical research and drug development.

Career Highlights: Kenyu Shibata is recognized for his pivotal role at Teikoku Hormone Mfg. Co., Ltd., where he has contributed to advancing research and development efforts within the pharmaceutical industry. His dedication to innovation has established him as a key figure in the company and a respected inventor in his field.

Collaborations: Throughout his career, Shibata has worked alongside talented colleagues such as Naoyuki Koizumi and Shigehiro Takegawa. These collaborations have enriched his research projects and fostered an environment of shared knowledge and innovation, further advancing the field of steroid compounds.

Conclusion: Kenyu Shibata's impressive patent portfolio and collaborative research efforts at Teikoku Hormone Mfg. Co., Ltd. demonstrate his commitment to innovation. His developments in oxa- and azasteroid compounds signify his impact in the realm of medicinal chemistry, showcasing the importance of teamwork and dedication in driving scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…